IL1B and Miyoshi myopathy: No significant difference was found for the overall survival of MM patients with CARD8-C10X (rs2043211) (P = 0.388), IL-1β (rs16944) (P = 0.714), IL-18 (rs1946518) (P = 0.882), or NF-κB-94 ins/del ATTG (P = 0.652).